Dakota Wealth Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Dakota Wealth Management's WST Position: Q3 2026 in Review
Dakota Wealth Management increased its West Pharmaceutical (WST) stake by 5.8% in Q3 2026, buying an estimated $665K and bringing the position to 34,453 shares worth $12.8M. The position accounts for 0.24% of the portfolio, ranked #89.
Dakota Wealth Management first reported a position in WST in Q2 2022 and has held it in 15 quarters since. 634 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Dakota Wealth Management held 34,453 shares of West Pharmaceutical worth $12.8M as of Q3 2026.
- Dakota Wealth Management bought 1,885 West Pharmaceutical shares in Q3 2026, an estimated $665K.
- West Pharmaceutical made up 0.24% of Dakota Wealth Management's portfolio in Q3 2026, its #89 holding.
- Dakota Wealth Management first reported a position in West Pharmaceutical in Q2 2022 and has held it in 15 quarters since.
- 634 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Dakota Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.